Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	90.32B -4.3%
Revenue (ttm)	89.16B +2.1%
Net Income	8.45B -14.9%
EPS	191.79 -14.9%
Shares Out	44.08M
PE Ratio	10.68
Forward PE	8.69
Dividend	50.00 (2.44%)
Ex-Dividend Date	Mar 30, 2026

Volume	119,200
Open	2,035.00
Previous Close	2,051.00
Day's Range	2,017.00 - 2,055.00
52-Week Range	1,878.00 - 2,434.00
Beta	0.06
Analysts	Strong Buy
Price Target	2,600.00 (+26.89%)
Earnings Date	Jul 30, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,746
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In fiscal year 2026, Zeria Pharmaceutical's revenue was 89.16 billion, an increase of 2.12% compared to the previous year's 87.31 billion. Earnings were 8.45 billion, a decrease of -14.92%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error